ViroPharma, Sanofi-Synthelabo SA deal

VPHM revised its 1995 agreement with Sanofi under which it had licensed exclusive U.S. and Canadian marketing rights to Sanofi’s pleconaril viral replication inhibitor. VPHM now will seek a partner wi...